Home » Seattle Genetics Seeks Tumor Drug Nod
Seattle Genetics Seeks Tumor Drug Nod
Seattle Genetics Inc. has submitted a request to the U.S. Food and Drug Administration to use the company’s antibody drug to treat relapses in Hodgkin lymphoma, the Bothell, Wash.-based company announced today.
Puget Sound Business Journal
Puget Sound Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May